KIR2DS4 and COVID-19: Higher frequencies for KIR2DS4 in severe COVID-19 patients and KIR3DS1+HLA-B*15:01+ in mild/moderate cases of COVID-19 than in control in Spanish indicate a potentially detrimental effect of activating KIR in COVID-19 (Bernal et al., 2021).